IFN-α/β-dependent cross-priming induced by specific toll-like receptor agonists

被引:11
|
作者
Durand, V [1 ]
Wong, SYC [1 ]
Tough, DF [1 ]
Le Bon, A [1 ]
机构
[1] Edward Jenner Inst Vaccine Res, Compton RG20 7NN, England
关键词
TLR; cross-priming; IFN-alpha/beta;
D O I
10.1016/j.vaccine.2005.01.115
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Toll-like receptors (TLR) are pattern recognition receptors that have been identified as crucial in the initiation of innate immune responses against pathogens. They are thought to be involved in shaping appropriate adaptive immune responses, although their precise contribution has not yet been fully characterised. Our aim was to investigate in vivo the effect of different TLR stimuli on cellular immune responses. We examined the ability of a range of TLR stimuli to induce CD8(+) T cell responses against a model soluble protein antigen, ovalbumin (OVA). We found that TLR 3, TLR 4, and TLR 9 agonists induced functional cross-priming, and that this process was dependent on IFN-alpha/beta signalling pathway. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:S22 / S23
页数:2
相关论文
共 50 条
  • [21] Differential involvement of IFN-β in Toll-like receptor-stimulated dendritic cell activation
    Hoshino, K
    Kaisho, T
    Iwabe, T
    Takeuchi, O
    Akira, S
    INTERNATIONAL IMMUNOLOGY, 2002, 14 (10) : 1225 - 1231
  • [22] Evidence for licensing of IFN-γ-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program
    Negishi, Hideo
    Fujita, Yasuyuki
    Yanai, Hideyuki
    Sakaguchi, Shinya
    Ouyang, Xinshou
    Shinohara, Masahiro
    Takayanagi, Hiroshi
    Ohba, Yusuke
    Taniguchi, Tadatsugu
    Honda, Kenya
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (41) : 15136 - 15141
  • [23] Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy
    Kirtland, Max E.
    Tsitoura, Daphne C.
    Durham, Stephen R.
    Shamji, Mohamed H.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [24] Toll-Like Receptor 9 Agonists for Cancer Therapy
    Melisi, Davide
    Frizziero, Melissa
    Tamburrino, Anna
    Zanotto, Marco
    Carbone, Carmine
    Piro, Geny
    Tortora, Giampaolo
    BIOMEDICINES, 2014, 2 (03) : 211 - 228
  • [25] Toll-like receptor agonists in adjuvant immunotherapy for cancer
    Farkas, A.
    Urosevic, M.
    Dummer, R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S21 - S21
  • [26] Toll-Like Receptor Agonists as Adjuvants for HIV Vaccines
    Stevceva, L.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (33) : 5079 - 5082
  • [27] Toll-like receptor agonists as cancer vaccine adjuvants
    Jeon, Donghwan
    Hill, Ethan
    Mcneel, Douglas G.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [28] Toll-Like Receptor Agonists for Treatment of Viral Infections
    Abdel-Magid, Ahmed F.
    ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (02): : 153 - 154
  • [29] Plant lectins are novel Toll-like receptor agonists
    Unitt, John
    Hornigold, David
    BIOCHEMICAL PHARMACOLOGY, 2011, 81 (11) : 1324 - 1328
  • [30] Toll-like receptor 9 agonists as cancer therapeutics
    Holtick, Udo
    Scheulen, Max E.
    von Bergwelt-Baildon, Michael S.
    Weihrauch, Martin R.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (03) : 361 - 372